Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowThe subsidiary, Prosidion Limited, is in the United Kingdom. Among its compounds is PSN010, which Lilly believes holds potential for fighting type 2 diabetes by rapidly lowering blood sugar levels by causing the liver to absorb more glucose and prompting the pancreas to secrete more insulin.
Please enable JavaScript to view this content.